BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10939750)

  • 1. Progression of renal failure in patients with compromised renal function is not always present: evaluation of underlying disease.
    Rottey S; Vanholder R; De Schoenmakere G; Lameire N
    Clin Nephrol; 2000 Jul; 54(1):1-10. PubMed ID: 10939750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untoward effects of chronic dual renin-angiotensin system blockade: influence of previous chronic renal failure.
    Robles NR; Cancho B; Barroso S; Martín MV; Sánchez Casado E
    Int J Clin Pract; 2006 Sep; 60(9):1035-9. PubMed ID: 16939543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database.
    Ardissino G; Viganò S; Testa S; Daccò V; Paglialonga F; Leoni A; Belingheri M; Avolio L; Ciofani A; Claris-Appiani A; Cusi D; Edefonti A; Ammenti A; Cecconi M; Fede C; Ghio L; La Manna A; Maringhini S; Papalia T; Pela I; Pisanello L; Ratsch IM;
    Nephrol Dial Transplant; 2007 Sep; 22(9):2525-30. PubMed ID: 17526542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function.
    Myers DI; Poole LJ; Imam K; Scheel PJ; Eustace JA
    Am J Kidney Dis; 2003 Feb; 41(2):351-9. PubMed ID: 12552496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical aspects and renal function in patients with endemic nephropathy].
    Bukvić D; Djukanović L; Janković S
    Srp Arh Celok Lek; 2003; 131(1-2):10-6. PubMed ID: 14608855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
    Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
    J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin.
    Ozsoy RC; van der Steeg WA; Kastelein JJ; Arisz L; Koopman MG
    Nephrol Dial Transplant; 2007 Jun; 22(6):1578-86. PubMed ID: 17347284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of iodinated contrast agents on residual renal function in PD patients.
    Moranne O; Willoteaux S; Pagniez D; Dequiedt P; Boulanger E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1040-5. PubMed ID: 16352623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.